Hodgkin lymphoma: open trials in Spain

26 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

2024-519498-20-00
A first time in man study to look at the safety of the experimental drug CCS1477 and what effects it has on cancers that affect the blood, bone marrow, lymph and lymphatic system.
Trial Treatment · Phase 1/2 · Cellcentric Limited
Institut Catala d'Oncologia, Badalona · Hospital Clinic de Barcelona, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario Infanta Leonor, Madrid · Clinica Universidad de Navarra, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario de la Princesa, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-05
2023-504264-41-00
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Trial Treatment · Phase 1/2 · F. Hoffmann-La Roche AG
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Infantil Universitario Nino Jesus, Madrid
Registry updated 2026-11-04
NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-11-04
NCT07226843
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Trial Treatment · Phase 1 · Eli Lilly and Company
Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario Fundación Jiménez Díaz, Madrid
Registry updated 2026-11-04
NCT07691606
A Study of ARC-02 in B-cell NHL
Trial Treatment · Phase 1 · Taiho Oncology, Inc.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital San Pedro De Alcántara, Cáceres · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-02
NCT07519772
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Institut Catala d'Oncologia, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen de la Victoria, Málaga
Registry updated 2026-10-29
NCT05607420
A Phase 1/2a Study of UCART20x22 in B-Cell Non-Hodgkin Lymphoma [NatHaLi-01]
Trial Treatment · Phase 1/2 · Cellectis
Hospital Universitari Vall d'Hebron, Barcelona · University Clinic of Navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-10-21
2023-505185-28-00
An early Phase 1b Study to assess how safe and effective is the treatment with drugs, called Mosunetuzumab or Glofitamab in Combination with drugs called, CC-220 and CC-99282 in Patients with B-Cell Non-Hodgkin Lymphoma.
Trial Treatment · Phase 1 · F. Hoffmann-La Roche AG
Hospital Universitari Vall d'Hebron, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Clinica Universidad de Navarra, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-20
NCT07192471
A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma
Trial Treatment · Phase 1 · Kyowa Kirin Inc.
Hospital Clinic de Barcelona, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Clinica Universidad de Navarra, Madrid · Clínica Universidad de navarra, Pamplona
Registry updated 2026-10-15
NCT06526793
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Trial Treatment · Phase 2 · AstraZeneca
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón
Registry updated 2026-10-14
NCT06137144
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Trial Treatment · Phase 1/2 · AstraZeneca
L'Hospitalet de Llobregat · Madrid
Registry updated 2026-10-13
NCT06173518
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Trial Treatment · Phase 1 · Autolus Limited
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Nino Jesus, Madrid
Registry updated 2026-10-09
NCT07582432
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Trial Treatment · Phase 3 · Grifols Biologicals, LLC
Institut catlá d'oncologia-Badalona, Badalona · Hospital San Pedro De Alcántara, Cáceres · Hospital Universitario Infanta Leonor, Madrid · Hospital Universitario de Navarra, Pamplona · Hospital Universitario Y Politecnico La Fe, Valencia · Clinica Universidad De Navarra · Hospital Universitario Quironsalud Madrid
Registry updated 2026-10-01
2024-513098-31-00
Study of MEN1703 in Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
Trial Treatment · Phase 2 · Ryvu Therapeutics S.A.
Hospital Universitari Vall d'Hebron, Barcelona · Clinica Universidad de Navarra, Madrid · MD Anderson Cancer Center, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · University Clinical Hospital Virgen De La Arrixaca, Murcia · Hospital Universitario de Navarra, Pamplona · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-09-27
2025-524915-36-00
A study to evaluate safety and clinical activity of GSK5926371 in adult participants with relapsed or refractory B-NHL
Trial Treatment · Phase 1/2 · Glaxosmithkline Research & Development Limited
Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario 12 de Octubre, Madrid · Complejo Asistencial Universitario de Salamanca, Salamanca · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-09-21
NCT04970901
A Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
Trial Treatment · Phase 1 · ADC Therapeutics SA
Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario Ramón y Cajal, Madrid · Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon, Madrid · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-09-15
2023-510173-34-00
A long-term follow-up study for patients treated with Galapagos CAR T cell therapies
Trial Treatment · Phase 3 · Lakefront Biotherapeutics
Hospital Clinic de Barcelona, Barcelona
Registry updated 2026-09-11
NCT05685173
A Trial to Study if REGN5837 in Combination with Odronextamab is Safe for Adult Participants with Aggressive B-cell Non-Hodgkin Lymphomas
Trial Treatment · Phase 1 · Regeneron Pharmaceuticals Inc.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-08-03
NCT04685616
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Trial Treatment · Phase 3 · University College, London
Hospital del Mar, Barcelona · Catalan Institute of Oncology, L'Hospitalet de Llobregat · Hospital Universitario de Navarra, Pamplona
Registry updated 2026-07-08
NCT06230224
A trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals Inc.
Hospital Universitario Virgen de las Nieves, Granada · Clinica Universidad de Navarra, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Clínica Universidad de navarra, Pamplona
Registry updated 2026-05-25
NCT03571568
Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcyRIIB), in Combination with Rituximab With or Without Acalabrutinib in Subjects with Indolent B-Cell Non-Hodgkin Lymphoma That Has Relapsed or is Refractory to Rituximab
Trial Treatment · Phase 1/2 · BioInvent International AB
Institut Catala d'Oncologia, Badalona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-04-17
NCT05991388
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Trial Treatment · Phase 2/3 · University of Birmingham
Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · Hospital Universitario La Paz, Madrid · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-02-20
NCT05544019
Study of SGR-1505 in Mature B-Cell Neoplasms
Trial Treatment · Phase 1 · Schrödinger, Inc.
Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario HM Sanchinarro, Madrid · Clinica Universidad de Navarra, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-02-13
2024-519790-19-00
IMMUNOTHERAPY WITH DIFFERENTIATED T CELLS, ADULTS, AUTOLOGOUS, FROM PERIPHERAL BLOOD, SELECTED BY CD62L EXPRESSION, EXPANDED AND TRANSDUCED (GENETICALLY MODIFIED) THROUGH A LENTIVIRAL VECTOR TO EXPRESS A CHIMERIC RECEPTOR WITH ANTI-CD19 SPECIFICITY ASSOCIATED WITH CO-STIMULATORY SEQUENCES 4-1-BB AND CD3Ζ IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA.
Trial Treatment · Phase 1/2 · Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Hospital de la Santa Creu i Sant Pau, Barcelona · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2025-09-29
2024-515063-66-00
Radiation-Free Therapy for the Initial treatment of Good prognosis early non-bulky HL, defined by a low Metabolic Tumor Volume and a negative interim PET after 2 chemotherapy cycles- RAFTING
Trial Treatment · Phase 2 · Medical University Of Gdansk
Institut Catala d'Oncologia, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario De Burgos, Burgos · Hospital Universitario De Leon, León · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario Ramón y Cajal, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Central De Asturias, Oviedo · University Hospital Son Espases, Palma · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2024-11-27

All Hodgkin lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error